Fightox 625 Tablet is a combination antibiotic containing Amoxycillin 500mg and Clavulanic Acid 125mg, designed to combat a wide range of bacterial infections. Amoxycillin, a penicillin-type antibiotic, works by inhibiting the synthesis of bacterial cell walls, leading to the destruction of susceptible bacteria. However, some bacteria produce an enzyme called beta-lactamase that can inactivate amoxycillin, rendering it ineffective. Clavulanic Acid acts as a beta-lactamase inhibitor, protecting amoxycillin from degradation and thereby extending its spectrum of activity against resistant bacteria. Fightox 625 is commonly prescribed for infections such as respiratory tract infections, urinary tract infections, skin and soft tissue infections, and sinusitis. It is effective against both gram-positive and gram-negative bacteria, including strains that produce beta-lactamase. The tablet should be taken as directed by a healthcare professional, usually every 8 to 12 hours, and it is important to complete the full course of therapy to prevent the development of antibiotic resistance. Common side effects may include gastrointestinal discomfort, diarrhea, and allergic reactions in sensitive individuals. Patients should inform their doctor of any allergies or other medications they are taking before starting Fightox 625.